Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordan J Feld

Showing results (261-270 of 333) with videos related to

Pageof 34
Sort By:
Viruses|September 7, 2019
Hepatitis C Core-Antigen Testing from Dried Blood SpotsMia J Biondi, Marjolein van Tilborg, David Smookler, et al.
Open Forum Infectious Diseases|February 17, 2018
Sofosbuvir-Based Direct-Acting Antiviral Therapies for HCV in People Receiving Opioid Substitution Therapy: An Analysis of Phase 3 StudiesJason Grebely, Jordan J Feld, David Wyles, et al.
Hepatology (Baltimore, Md.)|January 18, 2013
Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infectionJason Grebely, Jordan J Feld, Tanya Applegate, et al.
Journal of Viral Hepatitis|November 27, 2025
Pharmacist-Led Hepatitis C Diagnosis and Rapid Management-In Community (PHARM-C): Results From a Phase IV Nonblinded Randomised Controlled TrialMia J Biondi, Camelia I Capraru, Ben Harper, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 9, 2020
Reducing Read Time of Point-of-Care Test Does Not Affect Detection of Hepatitis C Virus and Reduces Need for Reflex RNADavid Smookler, Aaron Vanderhoff, Mia J Biondi, et al.
Hepatology Communications|December 6, 2023
IL-2 produced by HBV-specific T cells as a biomarker of viral control and predictor of response to PD-1 therapy across clinical phases of chronic hepatitis BConan Chua, Loghman Salimzadeh, Ann T Ma, et al.
The International Journal on Drug Policy|August 19, 2015
Recommendations for the management of hepatitis C virus infection among people who inject drugsJason Grebely, Geert Robaeys, Philip Bruggmann, et al.
The Journal of Clinical Investigation|April 15, 2025
Virus-associated inflammation imprints an inflammatory profile on monocyte-derived macrophages in the human liverJuan Diego Sanchez Vasquez, Shirin Nkongolo, Daniel Traum, et al.
JAMA|December 27, 2012
Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosisAdriaan J van der Meer, Bart J Veldt, Jordan J Feld, et al.
Lancet Regional Health. Americas|May 21, 2026
Rapid hepatitis C test and treat with peer support at opioid treatment programs (RAPID HCV): a hybrid effectiveness-implementation type 1 randomized control trialOluwaseun Falade-Nwulia, Jennifer C Price, Jordan J Feld, et al.
Pageof 34

Showing results (261-270 of 333) with videos related to

Sort By:
Pageof 34
Viruses|September 7, 2019
Hepatitis C Core-Antigen Testing from Dried Blood SpotsMia J Biondi, Marjolein van Tilborg, David Smookler, et al.
Open Forum Infectious Diseases|February 17, 2018
Sofosbuvir-Based Direct-Acting Antiviral Therapies for HCV in People Receiving Opioid Substitution Therapy: An Analysis of Phase 3 StudiesJason Grebely, Jordan J Feld, David Wyles, et al.
Hepatology (Baltimore, Md.)|January 18, 2013
Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infectionJason Grebely, Jordan J Feld, Tanya Applegate, et al.
Journal of Viral Hepatitis|November 27, 2025
Pharmacist-Led Hepatitis C Diagnosis and Rapid Management-In Community (PHARM-C): Results From a Phase IV Nonblinded Randomised Controlled TrialMia J Biondi, Camelia I Capraru, Ben Harper, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 9, 2020
Reducing Read Time of Point-of-Care Test Does Not Affect Detection of Hepatitis C Virus and Reduces Need for Reflex RNADavid Smookler, Aaron Vanderhoff, Mia J Biondi, et al.
Hepatology Communications|December 6, 2023
IL-2 produced by HBV-specific T cells as a biomarker of viral control and predictor of response to PD-1 therapy across clinical phases of chronic hepatitis BConan Chua, Loghman Salimzadeh, Ann T Ma, et al.
The International Journal on Drug Policy|August 19, 2015
Recommendations for the management of hepatitis C virus infection among people who inject drugsJason Grebely, Geert Robaeys, Philip Bruggmann, et al.
The Journal of Clinical Investigation|April 15, 2025
Virus-associated inflammation imprints an inflammatory profile on monocyte-derived macrophages in the human liverJuan Diego Sanchez Vasquez, Shirin Nkongolo, Daniel Traum, et al.
JAMA|December 27, 2012
Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosisAdriaan J van der Meer, Bart J Veldt, Jordan J Feld, et al.
Lancet Regional Health. Americas|May 21, 2026
Rapid hepatitis C test and treat with peer support at opioid treatment programs (RAPID HCV): a hybrid effectiveness-implementation type 1 randomized control trialOluwaseun Falade-Nwulia, Jennifer C Price, Jordan J Feld, et al.
Pageof 34